West Chester Capital Advisors, Inc Merck & Co., Inc. Transaction History

West Chester Capital Advisors, Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 03, 2021	SELL	$71.77 - $79.65 $226,506 - $251,375	-3,156 Closed	0 $0
Q3 2019 Nov 08, 2019	SELL	$76.08 - $82.93 $3,499 - $3,814	-46 Reduced 1.44%	3,156 $266,000
Q2 2019 Jul 30, 2019	SELL	$69.84 - $81.59 $209,520 - $244,770	-3,000 Reduced 48.37%	3,202 $268,000
Q1 2019 Apr 24, 2019	BUY	$69.58 - $79.36 $53,228 - $60,710	765 Added 14.07%	6,202 $516,000
Q4 2018 Feb 07, 2019	BUY	$65.24 - $75.71 $130,479 - $151,420	2,000 Added 58.19%	5,437 $415,000

Q3 2018 Oct 29, 2018	SELL	$57.69 - $67.84 $53,420 - $62,819	-926 Reduced 21.22%	3,437 $244,000
Q1 2018 May 04, 2018	SELL	$50.96 - $59.23 $30,117 - $35,004	-591 Reduced 11.93%	4,363 $238,000
Q4 2017 Feb 12, 2018	BUY	$51.62 - $61.64 $255,725 - $305,364	4,954	4,954 $274,000

3,768

1.87B

17.3M

14.8M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $319B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of West Chester Capital Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on West Chester Capital Advisors, Inc with notifications on news.